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Summary. Over 60% of bacterial infections (and up to 80% of chronic infections) are currently considered to involve
microbial growth in biofilms. This peculiar form of life poses an array of problems in human clinical practice, from infec-
tions associated with the implant of prosthetic devices and dental plaque formation to diseases such as cystic fibrosis, otitis
media, and endocarditis. Biofilms are also at the basis of a variety of problems in industry. This report describes the biofilms
produced by Streptococcus pneumoniae. This bacterium often colonizes the upper airways in humans as a normal commen-
sal, yet it may spread to other areas of the body, causing otitis media, pneumonia, or invasive diseases such as bacteremia and
meningitis. The capacity of S. pneumoniae to form biofilms had not been explored until recently. Several newly developed in
vitro systems have allowed to test the capacity of S. pneumoniae to form biofilms, and to analyze the influence of several fac-
tors, including DNA and proteins—which play a role in the virulence of this “supergerm” in the formation and development
of biofilms. In this brief review, we update the knowledge available on pneumococcal biofilm formation and the unusual fea-
tures of this structure. [Int Microbiol 2009; 12(2):77-85]
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General background
Among the samples routinely used by Anton van Leeuwen-
hoek to test his newly invented microscopes, were smears he
prepared from his own dental plaque, from which he was able
to observe bacteria, giving way to the discovery of microor-
ganisms. Van Leeuwenhoek could not have imagined that
bacteria of the oral cavity multiply to form the thin layers that
we today know as biofilms. In fact, precise knowledge of
such bacterial formations was not defined until 1978.
Subsequently, this knowledge became organized in the stud-
ies of the 1990s conducted mainly by Costerton’s group [8].
Biofilms are structured populations of microorganisms
adhered to a surface (or interface) and embedded in an extra-
cellular matrix consisting mainly of exopolysaccharides
(sometimes bound together by proteins and DNA) [20]. In
nature, these communities can be mono- or, more frequently,
multispecific [14,52] and show a modified phenotype in
terms of their growth rate and different gene expression pat-
terns. Biofilms have been likened in their level of organiza-
tion to a eukaryotic organism, undermining the frontier
between the biology of eukaryotes and prokaryotes [8]. The
polysaccharide surrounding the biofilm is frequently com-
posed of one or more anionic uronic acids. 
It is currently estimated that more than 60% of all human
bacterial infections are the result of microbial growth as
biofilms and of the inherent tolerance of these communities
to antibiotic agents and host immune defense mechanisms.
So far, the most overwhelming evidence of the pathogenic
relationship between humans and biofilms is based on
microscopy observations that have revealed the presence of
these communities at the site of infection (otitis caused by
pneumococcus, endocarditis by staphylococci, Pseudomonas
in the lungs of patients with cystic fibrosis, etc.) or in pros-
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thetic implants recovered from patients. Koch’s postulates
appear not to be applicable to biofilms given the peculiar fea-
tures of these cell aggregates [34]. 
Biofilm formation is in itself a simple strategy of micro-
bial survival that facilitates the spread of pathogens by pro-
viding a stable protective environment and acting as a reser-
voir for the dissemination of a large number of microorgan-
isms to new surfaces. We also know today that pathogenic
bacteria form biofilms in the lungs of patients with cystic
fibrosis and that a greater resistance to antibiotics seems to be
a characteristic feature of cells that live in a sessile state
(forming communities) compared to cells that adopt a plank-
tonic lifestyle (not attached to a surface) [6,9,34]. Microor-
ganisms in biofilms can be up to 1000 times more resistant to
antibiotics than the same free-living microorganisms. This
greater resistance has been attributed to the difficulty of
antimicrobial agents to penetrate a biofilm, to the short repli-
cation time of bacteria in this biological state, to the appear-
ance of modified microenvironments within the biofilm, or to
the above-mentioned antibiotic tolerance, although this last
property requires further investigation [4]. Some biofilms
play a protective role in humans; this is the case of vaginal
communities formed by lactobacilli that ferment glycogen
and reduce the vaginal pH, preventing its colonization by
diverse pathogens [13]. 
A multitude of factors regulate biofilm formation. Many
bacteria, including streptococci, are known to regulate
diverse physiological processes through a mechanism called
“quorum sensing” (QS). The QS, or autoinducer system, was
early described in Pseudomonas aeruginosa biofilms. In
gram-negative bacteria, the best known autoinducer is acyl
homoserine lactone, which can diffuse through the mem-
brane, while in gram-positive bacteria, signaling usually
involves the production of small linear or cyclic peptides that
are translated as a larger pro-peptide within the cell and then
processed during secretion [8]. Other QS systems participate
in interspecies cross-talk based on a signaling molecule orig-
inally described as autoinducer-2 (AI-2) and subsequently
identified as a furanone (furanosyl borate diester) (see below
and [29] and references therein). AI-2 is biosynthesized by
LuxS, the product of the luxS gene, in the S-adenosylhomo-
cysteine pathway [50]. It is noteworthy that the luxS gene
appears to be conserved in most gram-positive and gram-
negative bacteria. These external signal regulators allow for
the modulation inside the bacterial cell of the expression of
genes required for adaptation from the planktonic to the ses-
sile state. The control of these regulators is considered a good
target to avoid the formation of bacterial cell aggregates. In
fact, some years ago a study reported the isolation of an ana-
logue of homoserine lactone from the marine red alga
Delisea pulchra. This compound was designated “furanone”
[36] and was shown to interfere with bacterial communica-
tion by blocking the metabolic cascade that generates the QS
signal. Laboratory tests in which furanone was used to com-
bat P. aeruginosa infection in a mouse model have been suc-
cessful [63]. However, given the toxicity of furanone, other
types of molecules capable of inhibiting biofilm formation
need to be identified. P. aeruginosa biofilms grown in the
presence of synthetic furanone C-30 are significantly more
susceptible to tobramycin, an aminoglucoside antibiotic used
to treat cystic fibrosis [23]. Although the structure of the AI-2
produced by streptococci is still unknown, a synthetic bro-
mated furanone inhibits biofilm formation in several oral
streptococci, presumably through interference with the AI-2
signaling pathway [29].
Here, we briefly review the systems recently developed
for the analysis of biofilms produced by Streptococcus pneu-
moniae, the main causal agent of several serious diseases,
including pneumonia and otitis media. Special emphasis is
placed on the importance of visualizing biofilms using new
electron microscopy approaches designed to observe hydrated
structures in their natural state.
Pneumococcal biofilms
Streptococcus pneumoniae is a gram-positive facultative
anaerobe that often colonizes the nasopharynx of healthy
individuals. Nasopharyngeal colonization in the absence of
invasive disease provides S. pneumoniae with a stable envi-
ronment, from which it may be propagated to other hosts via
sneezing or mucus exchange. Thus, any microbial factor that
contributes to the in vivo growth and survival of S. pneumo-
niae, such as nasopharyngeal colonization, could be consid-
ered a virulence factor [32]. Note that the carrier state makes
biofilm development a “persistence factor,” as opposed to a
virulence factor per se [20]. Respiratory infections are
responsible for the death of 4 million people each year, and
S. pneumoniae is the predominant species in these infections
[39]. S. pneumoniae is also responsible for diseases such as
chronic otitis media (COM, accounting for 40% of these
infections), pneumonia, bacteremia, and meningitis. During
their first three years of life, approximately a third of all chil-
dren suffer three or more episodes of COM, possibly leading
to hearing loss. Pneumococcal biofilms have been detected in
the mucosa of the middle ear in children with COM [18] as
well as in a chinchilla model of otitis [46]. It has been pro-
posed that biofilm formation in vivo is intertwined with the
formation of extracellular neutrophil traps [56]. Until recently,
information on pneumococcal biofilms at the structural or
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genetic level was hardly available. The first system worked
out used continuous cultures in Sorbarods (cellulose) filters,
and was described in 1997 [7].
Biofilm structure and the intercellular matrix.
The initial stages of pneumococcal biofilm production on an
abiotic substrate such as polystyrene or glass have revealed
that, in its unencapsulated form, S. pneumoniae generates on
these surfaces three-dimensional structures some 25 μm in
depth, observable both by confocal laser scanning micros-
copy (CLSM) (Fig. 1) and by low-temperature scanning elec-
tron microscopy (LTSEM) (Fig. 2) [41]. In a recent fascinating
observation, bacterial aggregates, i.e., biofilms, were found to
adopt regular shapes to form honeycomb-like structures [51].
This conclusion has been reached by examining micro-
colonies by transmission electron microscopy, which entails
subjecting samples to freezing under high pressure to keep
the samples in a fully hydrated state. Our team has used a
similar method (LTSEM) [41] to obtain microscopy images
of S. pneumoniae yielding images comparable to those of
Staphylococcus epidermidis and P. aeruginosa, published by
Schaudinn et al. [51]. These structures, which are highly
organized (Fig. 2), occasionally disassociate from the cells
responsible for their formation. It seems that we have only
just begun to unveil the complexity of biofilms but we expect
to localize the genes involved in forming this type of struc-
ture, which is thought to help biofilms withstand the force of
the fluids that surround them. The elasticity of this structure
allows deformation in response to stress applied along any of
its six axes of symmetry in addition to providing mechanical
stability, which could be a major factor for virulence [51]. 
The presence of both extracellular DNA and certain pro-
teins (e.g., extracytoplasmic and surface-exposed proteins)
was found to influence biofilm formation in S. pneumoniae
[19,41]. However, Muñoz-Elías et al. did not detect any
effect of DNase I treatment on biofilm formation [42]. This
discrepancy could have resulted from the use of media, with
different effects on competence induction (Fig. 3) in pneu-
mococcus and thus on the amount of DNA released [40,41].
The importance of extracellular DNA in biofilm formation
has also been demonstrated in P. aeruginosa. Moreover, it
has been suggested that this bacterium undergoes pro-
grammed lysis and cell death depending on its spatial orien-
tation in the biofilm [57]. This in turn supports the idea that
cell lysis, as a matrix event, contributes to the biofilm’s struc-
tural stability [5,22]. Likewise, for S. pneumoniae it is known
that both competent and non-competent cells intervene in its
tendency to form aggregates under certain conditions, and
the capacity for aggregation is determined by DNA release
into the medium. A prerequisite for this process is the activi-
ty of the lytic enzymes LytA or LytC and CbpD. LytA and
CbpD also play a role in the lysis of non-competent cells in a
process known as “microbial fratricide,” which provides
their competent “sibling” cells with a pool of released DNA
[12,22,40]. Competent cells are protected against lysis by a
regulated immune function expressed during the state of
competence and mediated by the product of the gene comM.
This set of observations regarding death and cell lysis in S.
pneumoniae has prompted the study of biofilm maturation,
an issue that deserves particular attention in future studies on
the formation of biofilms in this model. 
In addition to DNA and proteins, increasing evidence
suggests that polysaccharides also form part of the extracel-
lular matrix of S. pneumoniae biofilms. Staining of the
biofilms with wheat germ agglutinin, which binds N-acetyl-
glucosamine, conjugated with a fluorescent compound, pro-
vided some evidence of the presence of an extracellular poly-
saccharide [11], although the authors could not determine
whether the label was due to N-acetylglucosamine residues
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Fig. 1. Confocal laser scanning microscopy image of the viability of biofilm-
grown S. pneumoniae R6 in C medium. After incubation at 34°C for 12 h,
the cells in the biofilms were stained with the BacLight kit, showing living
(green fluorescence) and dead (red fluorescence) bacteria. Bar = 30 μm.
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of the glycan chains of the cell-wall peptidoglycan, to the
capsular polysaccharide, or to a different extracellular com-
pound. More recently, Hall-Stoodley et al. used a nonencapsu-
lated pneumococcal strain and confirmed that biofilms of this
strain also bind lectins [19]. Nevertheless, the precise compo-
sition of the extracellular material remains to be determined.
Colonization, biofilm formation and capsular
polysaccharide. A minimum amount of the capsular
polysaccharide (CPS) is absolutely required for efficient
nasopharyngeal colonization in mice [35], although the cap-
sule must be subsequently recovered for survival during sys-
temic invasion of the host [31]. More recently and also using
a mouse model, it was reported that nonencapsulated pneu-
mococcal mutants retain their capacity for nasal colonization
but at a reduced density and duration compared to their
encapsulated parent strains [43]. This impaired colonization
could be attributed to the fact that nonencapsulated mutants
remain agglutinated within luminal mucus and are thus less
likely to reach the epithelial surface, where stable coloniza-
tion occurs.
Pneumococcal strains of serotypes showing greatest
adhesion to polystyrene have a higher capacity to produce
otitis media in animal models, such as gerbils, than serotypes
poorly adhering to polystyrene [24]. However, several
reports have documented that nonencapsulated pneumococ-
cal mutants show increased adhesion properties and are
therefore more prone than their encapsulated parents to form
biofilms in vitro [2,38,41,42,58,59]. This observation is
directly related to the fact that the capsule is a limiting factor
for pneumococcal adhesion to the cells of the nasopharynx,
while it plays an essential protective role against phagocyto-
sis during invasive infection (see above). Several different
mutations were found among the type 3 capsular mutants that
appeared in biofilms formed on polystyrene plates. Most
strains contained single nucleotide polymorphisms in cap3A,
the first gene of the type 3 capsular operon [16], one had a
mutated –10 promoter hexamer (CATAAT), and three had
large deletions affecting cap3A and, in one case, also cap3B
(Domenech et al., submitted for publication). This contrasts
with previously described phase variants containing
reversible tandem sequence duplications within cap3A; these
variants were obtained when biofilms were allowed to form
under continuous culture using Sorbarod filters [59]. Similar
results were later reported when type 8 or type 37 pneumo-
cocci were analyzed using the same Sorbarod system [58].
However, when biofilms were produced as a continuous flow
tube reactor biofilm [2], the nonmucoid variants that
appeared lacked most of the cap3 operon because of a
lengthy (>7 kb) deletion. Moreover, plate-based biofilms on
membrane filters gave rise to different kinds of type 3 capsu-
lar mutants upon extended growth (4–7 days) [38]. These
results strongly suggest that the method chosen for biofilm
formation modulates, in some unknown way, the kinds of
capsular mutations that will appear in the culture. Indeed,
experimental evidence suggests that environmental condi-
tions specific to biofilm growth substantially increase muta-
tion frequencies [3]. In addition, in an elegant electron
microscopy study [21] on cultured epithelial cells, neither
serotype 3 pneumococci in close contact with the host cell
membrane nor invading pneumococci had a visible capsular
structure, whereas pneumococci not in close contact with the
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Fig. 2. Low-temperature scanning electron microscopy analysis of pneumococcal biofilms. (A) Honeycomb-like structures produced by Strepto-
coccus pneumoniae biofilms, in which some cells are associated with the walls of these structures. (B) Detail of another area of the same biofilm,
in which the bacterial cells are inside a honeycomb structure; clumps of cells bound by filamentous material can be seen.
81INT. MICROBIOL. Vol.12, 2009
host membrane had a typical capsule. In addition, S. pneumo-
niae cells expressed CPS in the lungs of infected mice,
whereas bacteria in contact with lung epithelial tissue
showed a drastic reduction in the density of the CPS layer.
Proteins involved in biofilm formation. Several
recent works have established the basis to explore the gene
products involved in the formation of biofims of S. pneumo-
niae. In biofilms produced using a continuous-culture sys-
tem, proteomic analysis showed that biofilm development
correlated not only with the differential production of pro-
teins but also with a dramatic increase in the number of
detectable proteins [1]. Protein identification revealed that
several proteins involved in virulence, adhesion, and resist-
ance were more abundant under biofilm growth conditions.
Oggioni and collaborators reported that, in the blood of mice
inoculated intravenously (septic mice), pneumococci showed
a pattern of gene expression very similar to that in mid-expo-
nential phase of growth in liquid culture whereas, for nearly
all the genes studied, the expression pattern was identical in
pneumococci recovered from tissue and from biofilm [44].
Furthermore, whereas pneumolysin was overexpressed in
biofilms formed under continuous culture conditions [1], the
pneumolysin-coding gene (ply) was repressed in poly-
styrene-grown biofilms [44]. Whether this (and other) dis-
crepancies are related to differences in the strains used and/or
to the biofilm-forming conditions remains to be determined.
The role in biofilm formation of choline binding proteins,
which anchor to the choline residues of the cell-wall teichoic
acids, was studied using unambiguously characterized
PNEUMOCOCCAL BIOFILMS
Fig. 3. The induction of competence for genetic transformation in Streptococcus pneumoniae. Competence in pneumococcus is regu-
lated by a QS system via CSP. CSP is derived from the precursor protein ComC and it is cleaved and exported by the ATP-binding
cassette transporter system, ComAB. When a critical extracellular concentration of CSP is reached, the signaling cascade begins with
interaction of CSP with its histidine kinase receptor, ComD. It is likely that ComD passes on the signal by transferring a phosphate
group to the cognate response regulator, ComE. Phosphorylated ComE activates the transcription of early com genes: comCDE,
comAB, comX, and comW. ComX, encoded by two identical genes, acts as an alternative sigma factor that initiates transcription of the
genes required for DNA uptake and recombination, and of late com genes. ComW is a positive regulator of competence that could
promote the assembly of ComX with RNA polymerase by protection from proteolysis, by modification of σX to an active form, or by
stabilization of the σX-holoenzyme.
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mutants. The results showed that LytA amidase, LytC
lysozyme, LytB glucosaminidase, CbpA adhesin, PcpA puta-
tive adhesin, and PspA (pneumococcal surface protein A)
mutants had a decreased capacity to form biofilms, whereas
no such reduction was observed in Pce phospho-
cholinesterase or CbpD putative amidase mutants [41]. More
recently, 69 mutants with insertions in 42 different genes and
eight promoters, showing altered biofilm formation, were
studied [42]. It was found, for instance, that lytC or cbpA
mutants were poor biofilm formers, in agreement with previ-
ous findings [41]. Moreover, an additional choline binding
protein (SP0391) was required for optimal biofilm formation
[42], whereas interruption of the gene encoding SP1538, a
putative protein/peptidyl-prolyl cis-trans isomerase, led to
drastic inhibition of biofilm formation [42]. SP1538 was
reported to be overexpressed by S. pneumoniae forming
biofilms [1]. Interestingly, encapsulated serotype 2 pneumo-
cocci having mutations in SP1538, cbpD or SP0391 (among
other genes) were severely compromised in their ability to
colonize the nasopharynx in a mouse model of infection [42]. 
Quorum sensing systems and biofilms. Loo et
al. [30] first reported that biofilm formation in one strepto-
coccal species (Streptococcus gordonii) involves QS.
Afterwards, several studies confirmed that the QS system
promotes the formation of biofilms in streptococci, and that,
in a biofilm, Streptococcus intermedius takes up tenfold more
DNA from the medium than its free-living counterparts [55].
More recently, it was proposed that the system regulating the
development of competence for the bacterial transformation
process in S. pneumoniae, made up of phosphotransfer sig-
nals involving two proteins that detect an environmental sig-
nal (in this case a so-called competence-stimulating peptide,
or CSP) (Fig. 3), plays a role in colonization of the respiratory
tract [27]. Some authors have noted that induction of the
competence system by the QS CSP signal promotes biofilm
formation in vitro, and pneumococcal cells recovered from
these biofilms show enhanced virulence in models of pneu-
monia and meningitis [44]. In contrast, planktonic cells test-
ed in animal models were more efficient at inducing sepsis.
These data suggest that during host infection invasive pneu-
mococci should exist in two physiological states. In addition,
during tissue infection S. pneumoniae were visualized in a
state resembling a biofilm [44]. 
As mentioned above, the LuxS protein is required for the
biosynthesis of AI-2, which is involved in QS in a wide range
of bacterial species. Although not yet confirmed in biofilms,
it has been reported that, although a luxS mutant was able to
colonize the nasopharynx of the mouse as efficiently as the
wild-type strain, it was less able to spread from the nasophar-
ynx to the lungs or the blood [54]. Moreover, a profound
defect of the mutant in its ability to persist in the nasopharyn-
geal tissues was noted [26]. Lastly, increased expression of
luxS under all in vivo conditions (including biofilms) has
been observed [44].
Future prospects 
According to a recent report by the WHO, pneumonia is the
main cause of death of children less than 5 years of age, sur-
passing deaths caused by AIDS, malaria, and measles together.
Two-thirds of these more than 2 million children die in 15
countries, with S. pneumoniae and Haemophilus influenzae
type Ib identified as the main causal agents of acute pneumo-
nia in children in developing countries [60]. The paucity of
research devoted to these bacteria has precluded their better
control.
Biofilms are now recognized as etiological agents in
many chronic infections affecting tissues and surgical
implants. Estimates of the clinical costs generated by infec-
tions involving biofilms are already high. Thus, in bac-
teremia that develops in adults dependent on hemodialysis,
these costs have been calculated to range from US$ 17,000 in
mild cases to US$ 32,000 in bacteremia with complications.
Costs for surgical infections in prosthetic implants can, for
example, in the case of orthopedic implants for fracture fixa-
tion, amount to US$ 50,000 per patient [34]. As already dis-
cussed, preventing or limiting colonization by biofilms is
likely to be the most effective procedure for the control of
this type of infection. Arguably, the routine use of antibiotics
to eliminate biofilms is, to say the least, a dubious strategy,
and this practice could further aggravate the already worri-
some situation of hospital-acquired infections. Antibiotics
usually fail in certain infections caused by pneumococcus,
such as otitis media. This type of recurrent infection involves
the formation of a biofilm in the mucosa by the same strain
of the microorganism that we thought had been eradicated by
antibiotics, and not by a second infective agent as has been
postulated [37].
Recent studies have shown that the combined action of
S. pneumoniae and a respiratory virus variant contributes to
the formation of these bacterial aggregates. The recurrent
infections produced in many of the 24 million people diag-
nosed with otitis media every year in the USA are currently
treated with antibiotics; however, a novel experimental sys-
tem has been developed using a mouse model in which
intranasal infection with S. pneumoniae is induced. In the
presence of an influenza virus, 70% of the animals develop
otitis media. The most revealing finding of this study was
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that the administration of a phage lytic enzyme (Cpl-1)
before provoking the middle ear infection in the presence of
the virus prevented biofilm formation [37]. Phage lytic
enzymes are murein hydrolases responsible for the release of
phage progeny after bacterial infection. In our laboratory, a
series of pneumococcal lytic enzymes has been analyzed in
detail [17]. These enzymes have been used in in vitro studies
in murine models developed to eliminate both nasal and sys-
temic infections [25,47] and were originally designed as
“enzybiotics” [15,28]. However, while this model to elimi-
nate otitis media is based on preventive treatment with a
phage lysin, another model has been developed in which
already formed biofilms are eliminated using bacteriophages
that have been genetically modified to express an enzyme
capable of degrading the biofilm. This phage therapy resulted
in the elimination of 99% of the biofilms formed by
Escherichia coli [33]. It has also been reported that an organic
compound identified as cis-2-decenoic acid induces the dis-
persion of biofilm microcolonies of P. aeruginosa and other
microorganisms, including several gram-positive species
[10]. Note that cis-2-decenoic acid is known to be involved
in interspecies communication in bacteria [49]. These alter-
native or complementary treatments to antibiotic therapy
acquire special relevance if we consider that, in addition to
the passive resistance to antibiotics of biofilm-residing cells,
in P. aeruginosa a genetically programmed flow pump that
confers resistance to tobramycin, gentamicin, and cipro-
floxacin has been newly identified. While the genes involved
in this process are strongly expressed in biofilm cells, they
are very weakly expressed in their planktonic counterparts
[64].
The isolation of axenic bacterial cultures has played a key
role in the development of microbial chemotherapies.
However, in view of our current understanding of the signif-
icance of biofilms, this simple analysis is rendered largely
incomplete. The complex world of biofilms co-inhabited by
polymicrobial communities reflects a more complex reality
that requires new experimental rationales. We are just begin-
ning to appreciate that extensive, thorough knowledge of
these pathogens is critical to designing treatments and to
adopting new health control measures [60]. The availability
of experimental models to examine biofilm formation by a
human pathogen of the significance of pneumococcus would
help to advance our knowledge of cell-to-cell communica-
tion. An understanding of QS systems and concomitant DNA
transfer via genetic transformation, both of which have been
well studied in planktonic cultures [40], would enable the
analysis of issues such as the passive resistance to antibiotics
of these cell communities, including the phenomenon of
antibiotic tolerance. In contrast, it is thought that the honey-
comb structure of extracellular polymeric substances is a
peculiar feature of each microorganism, implying that their
formation is subject to genetic control. Moreover, when the
culture is transferred, the gene cycle responsible for the
development of each community is repeated, which suggests
that the ontogeny of these structures is as reproducible as that
of the embryos of higher organisms [51]. 
Finally, a subject of particular interest is the mechanism
that underlies biofilm dispersion. A mechanism proposed
early on is that of mechanical transmission provoked by
shear forces. In P. aeruginosa, the presence of a bacterio-
phage (Pf4) in the prophage state leads to phenotypic varia-
tions in this bacterium. This suggests programmed mobiliza-
tion of live cells, so-called persisters, that subsequently
establish a new colony in the biofilm at a new site with the
colonizers, or settlers [61]. In addition, several studies have
shown that these temperate phage genes are among those
most up-regulated genes in biofilm formation [53,62].
Considering that over 70% of recent clinical isolates of pneu-
mococcus are lysogenic [45,48], the study in this system of
the relationship between biofilm development and bacterio-
phages is of special interest. 
Infectious diseases are still leaders in the number of
deaths they cause and tragedies they provoke [39]. Along
with the appearance of new causal agents of infectious dis-
eases (AIDS, Lyme, Ebola), old acquaintances, such as P.
aeruginosa, Staphylococcus, pneumococcus and many more,
as well as apparently innocuous bacteria, such as Moraxella
and Legionella, have started to reveal their extraordinary ver-
satility in giving rise to complex structures such as biofilms.
It now emerges that biofilms have been and still are today the
most common mode of initiating an infection. Clearly, we
need to improve our understanding of the dynamic relationship
among the bacterium, the host, and the environment. The
issues discussed here document new compelling research lines
in the study of these cellular aggregates in a system of such
major clinical importance as pneumococcus infections. 
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